---
title: "SIM0725 receives NMPA approval to begin clinical trials in China — DecisionGateway"
description: "SIM0725 receives NMPA approval to begin clinical trials in China"
canonical_url: "https://dgw.tmarket.io/events/01a1d903-dece-7e9f-be3e-2a0ea68bbc0b"
meta:
  "og:description": "SIM0725 receives NMPA approval to begin clinical trials in China"
  "og:image": "https://dgw.tmarket.io/og.jpg"
  "og:image:alt": "White network of connected nodes crossed by a timeline on black"
  "og:image:height": "1024"
  "og:image:width": "1024"
  "og:title": "SIM0725 receives NMPA approval to begin clinical trials in China — DecisionGateway"
  "twitter:image": "https://dgw.tmarket.io/og.jpg"
---

> Index of every page on this site: [llms.txt](https://dgw.tmarket.io/llms.txt)

**Event**/Approval

**Completed**

# **SIM0725 receives NMPA approval to begin clinical trials in China**

## **Actors and targets**

[先聲藥業集團initiator](https://dgw.tmarket.io/actors/01a1d903-deb0-7451-9aea-911c778a672b)

[**先聲藥業集團 dossier **](https://dgw.tmarket.io/actors/01a1d903-deb0-7451-9aea-911c778a672b)

## **Source**

No source quote is linked to this record.

## **Related events**

Same kind only, ranked by embedding similarity to this record.

```json
{"@context":"https://schema.org","@graph":[{"@id":"https://dgw.tmarket.io/#website","@type":"WebSite","description":"Decisions, events and falsifiable forecasts from 4,000+ Telegram channels — every claim cited. Read free.","name":"DecisionGateway","url":"https://dgw.tmarket.io/","publisher":{"@id":"https://dgw.tmarket.io/#identity"}},{"@id":"https://dgw.tmarket.io/events/01a1d903-dece-7e9f-be3e-2a0ea68bbc0b#webpage","@type":"WebPage","description":"SIM0725 receives NMPA approval to begin clinical trials in China","name":"SIM0725 receives NMPA approval to begin clinical trials in China — DecisionGateway","url":"https://dgw.tmarket.io/events/01a1d903-dece-7e9f-be3e-2a0ea68bbc0b","breadcrumb":{"@id":"https://dgw.tmarket.io/events/01a1d903-dece-7e9f-be3e-2a0ea68bbc0b#breadcrumb"},"isPartOf":{"@id":"https://dgw.tmarket.io/#website"},"potentialAction":[{"@type":"ReadAction","target":["https://dgw.tmarket.io/events/01a1d903-dece-7e9f-be3e-2a0ea68bbc0b"]}]},{"@id":"https://dgw.tmarket.io/#identity","@type":"Organization","name":"DecisionGateway","url":"https://dgw.tmarket.io"},{"@id":"https://dgw.tmarket.io/events/01a1d903-dece-7e9f-be3e-2a0ea68bbc0b#breadcrumb","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","name":"Home","item":"https://dgw.tmarket.io","position":1},{"@type":"ListItem","name":"Feed","item":"https://dgw.tmarket.io/feed","position":2},{"@type":"ListItem","name":"SIM0725 receives NMPA approval to begin clinical trials in China","position":3}]}]}
```

## Sitemap

See the full [sitemap](https://dgw.tmarket.io/sitemap.md) for all pages.